Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The ...

A new study suggests that a Sinopharm vaccine offers poor protection from COVID-19 among the elderly, raising questions for dozens of countries that have given the Chinese company’s shots to their ...

I leave my existing Hold rating for Sinopharm Group unchanged after analyzing the company's key profitability and working capital metrics. SHTDF's days sales outstanding metric could get better as a ...

BEIJING, June 2 (Reuters) - China National Pharmaceutical Group (Sinopharm) has the capacity to provide more than 1 billion COVID-19 vaccine doses to the world beyond China in the second half of this ...

HONG KONG (Reuters Breakingviews) - Herbal remedies usually take a while to work. In Sinopharm's case, two years may be enough. The Chinese pharmaceutical giant may revive a buyout of its 32%-owned ...

Two vaccines made by China’s Sinopharm appear safe and effective against COVID-19, according to a study published in a medical journal. Scientists had been waiting for more details about the two ...

China National Pharmaceutical Group Co. is considering a revived bid for China Traditional Chinese Medicine Holdings Co. that could value the Hong Kong-listed drugmaker at around $4 billion, people ...

Investors pursuing a solid, dependable stock investment can often be led to Sinopharm Group Co Ltd (HKG:1099), a large-cap worth HK$103.4b. Doing business globally, large caps tend to have diversified ...

In Mongolia, hospitals are overwhelmed. In the tiny archipelago of Seychelles, more than 100 new Covid-19 cases are being reported each day. And in Chile, a nationwide lockdown was lifted this week – ...

China's Sinopharm COVID-19 Vaccine Shows 79.34% Efficacy China's Sinopharm Group (OTC: SHTDY) said Wednesday its COVID-19 vaccine candidate BBIBP-CorV — developed in partnership with Beijing ...